University of California San Francisco
Give to UCSF
The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UCSF researchers have found in a new study.
One of the world’s preeminent cancer scientists, Alan Ashworth, PhD, FRS, has been appointed the new director of the UCSF Helen Diller Family Comprehensive Cancer Center.
Laura van ‘t Veer, PhD, was honored this week as one of the top female scientific innovators in Europe, winning one of the 2014 European Union Prizes for Women Innovators.
New guidelines recommending screening mammography every two years for women ages 50 to 74 would save the United States $4.3 billion a year in health care costs, according to a UCSF-led study.
Scientists have discovered a type of RNA that could have enormous potential for better diagnosing and treating many types of cancer, Alzheimer's, multiple sclerosis and other diseases.
Pamela Munster, MD, is program leader of Developmental Therapeutics at UCSF’s Helen Diller Family Comprehensive Cancer Center. She shares a breast cancer story here – her own.
Often deadly “triple-negative” breast cancers might be effectively treated in many cases with a drug that targets a previously unknown vulnerability in the tumors, UCSF reports.
A team of researchers at UCSF is incorporating genomics into a broad group of potential factors that can help clinicians better understand which patients are at greatest risk for persistent postsurgical pain and how to better prevent or treat it.
